Hong Kong · Delayed Price · Currency is HKD C-MER Medical Holdings Statistics
Total Valuation
HKG:3309 has a market cap or net worth of HKD 1.51 billion. The enterprise value is 1.63 billion.
| Market Cap | 1.51B |
| Enterprise Value | 1.63B |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
HKG:3309 has 1.19 billion shares outstanding. The number of shares has decreased by -2.26% in one year.
| Current Share Class | 1.19B |
| Shares Outstanding | 1.19B |
| Shares Change (YoY) | -2.26% |
| Shares Change (QoQ) | -1.36% |
| Owned by Insiders (%) | 2.14% |
| Owned by Institutions (%) | 2.81% |
| Float | 483.41M |
Valuation Ratios
The trailing PE ratio is 15.25.
| PE Ratio | 15.25 |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 0.78 |
| P/TBV Ratio | 1.49 |
| P/FCF Ratio | 7.34 |
| P/OCF Ratio | 5.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.79, with an EV/FCF ratio of 7.93.
| EV / Earnings | 16.27 |
| EV / Sales | 0.84 |
| EV / EBITDA | 4.79 |
| EV / EBIT | 11.49 |
| EV / FCF | 7.93 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.43 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.25 |
| Debt / FCF | 2.07 |
| Interest Coverage | 5.86 |
Financial Efficiency
Return on equity (ROE) is 5.81% and return on invested capital (ROIC) is 5.37%.
| Return on Equity (ROE) | 5.81% |
| Return on Assets (ROA) | 3.27% |
| Return on Invested Capital (ROIC) | 5.37% |
| Return on Capital Employed (ROCE) | 6.30% |
| Weighted Average Cost of Capital (WACC) | 6.45% |
| Revenue Per Employee | 889,316 |
| Profits Per Employee | 45,850 |
| Employee Count | 2,189 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 25.32 |
Taxes
In the past 12 months, HKG:3309 has paid 44.35 million in taxes.
| Income Tax | 44.35M |
| Effective Tax Rate | 28.51% |
Stock Price Statistics
The stock price has decreased by -18.06% in the last 52 weeks. The beta is 0.52, so HKG:3309's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -18.06% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 42.27 |
| Average Volume (20 Days) | 373,916 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:3309 had revenue of HKD 1.95 billion and earned 100.37 million in profits. Earnings per share was 0.08.
| Revenue | 1.95B |
| Gross Profit | 603.67M |
| Operating Income | 142.60M |
| Pretax Income | 155.52M |
| Net Income | 100.37M |
| EBITDA | 206.52M |
| EBIT | 142.60M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 465.96 million in cash and 426.78 million in debt, with a net cash position of 39.18 million or 0.03 per share.
| Cash & Cash Equivalents | 465.96M |
| Total Debt | 426.78M |
| Net Cash | 39.18M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 1.94B |
| Book Value Per Share | 1.49 |
| Working Capital | 203.00M |
Cash Flow
In the last 12 months, operating cash flow was 283.29 million and capital expenditures -77.52 million, giving a free cash flow of 205.77 million.
| Operating Cash Flow | 283.29M |
| Capital Expenditures | -77.52M |
| Depreciation & Amortization | 63.91M |
| Net Borrowing | -118.17M |
| Free Cash Flow | 205.77M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 31.01%, with operating and profit margins of 7.33% and 5.16%.
| Gross Margin | 31.01% |
| Operating Margin | 7.33% |
| Pretax Margin | 7.99% |
| Profit Margin | 5.16% |
| EBITDA Margin | 10.61% |
| EBIT Margin | 7.33% |
| FCF Margin | 10.57% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.57%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 1.57% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 28.77% |
| Buyback Yield | 2.26% |
| Shareholder Yield | 3.86% |
| Earnings Yield | 6.65% |
| FCF Yield | 13.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:3309 has an Altman Z-Score of 2.64 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.64 |
| Piotroski F-Score | 5 |